Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M Connors

Showing results (291-300 of 302) with videos related to

Pageof 31
Sort By:
The New England Journal of Medicine|June 9, 2006
Molecular diagnosis of Burkitt's lymphomaSandeep S Dave, Kai Fu, George W Wright, et al.
Cancer Cell|March 7, 2003
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphomaAndreas Rosenwald, George Wright, Adrian Wiestner, et al.
The New England Journal of Medicine|November 19, 2004
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cellsSandeep S Dave, George Wright, Bruce Tan, et al.
The New England Journal of Medicine|April 12, 2018
Genetics and Pathogenesis of Diffuse Large B-Cell LymphomaRoland Schmitz, George W Wright, Da Wei Huang, et al.
Nature|January 8, 2010
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphomaR Eric Davis, Vu N Ngo, Georg Lenz, et al.
Nature|August 14, 2012
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomicsRoland Schmitz, Ryan M Young, Michele Ceribelli, et al.
The New England Journal of Medicine|June 21, 2002
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphomaAndreas Rosenwald, George Wright, Wing C Chan, et al.
Nature|July 29, 2011
Frequent mutation of histone-modifying genes in non-Hodgkin lymphomaRyan D Morin, Maria Mendez-Lago, Andrew J Mungall, et al.
Nature Medicine|February 26, 2020
TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphomaDaisuke Ennishi, Shannon Healy, Ali Bashashati, et al.
Journal of the National Cancer Institute. Monographs|September 1, 2014
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectLindsay M Morton, Susan L Slager, James R Cerhan, et al.
Pageof 31

Showing results (291-300 of 302) with videos related to

Sort By:
Pageof 31
The New England Journal of Medicine|June 9, 2006
Molecular diagnosis of Burkitt's lymphomaSandeep S Dave, Kai Fu, George W Wright, et al.
Cancer Cell|March 7, 2003
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphomaAndreas Rosenwald, George Wright, Adrian Wiestner, et al.
The New England Journal of Medicine|November 19, 2004
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cellsSandeep S Dave, George Wright, Bruce Tan, et al.
The New England Journal of Medicine|April 12, 2018
Genetics and Pathogenesis of Diffuse Large B-Cell LymphomaRoland Schmitz, George W Wright, Da Wei Huang, et al.
Nature|January 8, 2010
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphomaR Eric Davis, Vu N Ngo, Georg Lenz, et al.
Nature|August 14, 2012
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomicsRoland Schmitz, Ryan M Young, Michele Ceribelli, et al.
The New England Journal of Medicine|June 21, 2002
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphomaAndreas Rosenwald, George Wright, Wing C Chan, et al.
Nature|July 29, 2011
Frequent mutation of histone-modifying genes in non-Hodgkin lymphomaRyan D Morin, Maria Mendez-Lago, Andrew J Mungall, et al.
Nature Medicine|February 26, 2020
TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphomaDaisuke Ennishi, Shannon Healy, Ali Bashashati, et al.
Journal of the National Cancer Institute. Monographs|September 1, 2014
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectLindsay M Morton, Susan L Slager, James R Cerhan, et al.
Pageof 31